Multi-hit STAG2 mutations define a high-risk subset of MDS and reveal convergent evolutionary targeting of cohesin
Authors:
Preprint
Abstract
STAG2 is the most frequently mutated cohesin gene in myeloid neoplasms, yet the significance of multiple mutations within this X-linked tumor suppressor remains unknown. We analyzed a cohort of 1,967 adult patients with myeloid neoplasms and identified 233 cases (12%) harboring STAG2 mutations, including 38 cases (16%) with multiple STAG2 hits. Patients with multi-hit STAG2 mutations exhibited increased multilineage dysplasia compared with single-hit cases and experienced inferior overall survival, an effect driven primarily by patients with myelodysplastic syndromes (MDS). To investigate the molecular basis of recurrent STAG2 acquisition, we performed long-read sequencing in representative cases with phaseable STAG2 mutations. In the informative case examined, distinct truncating STAG2 mutations did not co-occur on the same DNA molecule, supporting independent acquisition rather than stepwise allelic inactivation. Cohort-level variant allele frequency patterns were consistent with recurrent evolutionary targeting of STAG2 across related clonal populations. Together, these findings support a model in which multi-hit STAG2 mutations arise through convergent evolution and define a biologically distinct, adverse-risk subset of MDS. Key points: Multi-hit STAG2 mutations identify a high-risk subset of MDS characterized by increased multilineage dysplasia and inferior survival. Long-read sequencing supports convergent evolutionary acquisition of STAG2 mutations rather than stepwise allelic inactivation.Keywords
Funding Information
- Damon Runyon Cancer Research Foundation (Damon-Runyon-Doris Duke Clinical Investigator (CI-120-22))
- Doris Duke Charitable Foundation (Clinician Scientist Development Award)
- NIH/NCI Cancer Center Support Grant (P30CA012696)
- NCATS Clinical and Translational Science Awards (CTSA) Grant (UL1TR001873)
- Genomics and High Throughput Screening Shared Resource
This publication has 36 references indexed in Scilit:
- STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemiaCell Reports, 2024
- Chromatin organization in myelodysplastic syndromeExperimental Hematology, 2024
- Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasmsLeukemia, 2020
- Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and DifferentiationCell Stem Cell, 2019
- Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming itBlood Reviews, 2019
- Cohesin mutations in human cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2016
- Incidence and Burden of the Myelodysplastic SyndromesCurrent Hematologic Malignancy Reports, 2015
- Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia RegistryAmerican Journal of Hematology, 2014
- PyClone: statistical inference of clonal population structure in cancerNature Methods, 2014
- Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasmsNature Genetics, 2013